Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
9.48 (1y: +37%)
Market Cap 133.25 M P/E(ttm)
Enterprise Value 45.15 M P/B 1.40
CUTR- NAS (USA)
Cutera, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$9.48
Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry		 vs
history
Cash to Debt No Debt
CUTR's Cash to Debt is ranked lower than
469483% of the 213 Companies
in the Global Medical Devices industry.

( Industry Median: 6.22 vs. CUTR: No Debt )
CUTR' s 10-Year Cash to Debt Range
Min: No Debt   Max: No Debt
Current: No Debt
Equity to Asset 0.77
CUTR's Equity to Asset is ranked lower than
518134% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 0.58 vs. CUTR: 0.77 )
CUTR' s 10-Year Equity to Asset Range
Min: -0.27   Max: 0.86
Current: 0.77
-0.27
0.86
Interest Coverage No Debt
CUTR's Interest Coverage is ranked lower than
617283% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 249.00 vs. CUTR: No Debt )
CUTR' s 10-Year Interest Coverage Range
Min: No Debt   Max: No Debt
Current: No Debt
F-Score: 4
Z-Score: 5.35
M-Score: -2.34
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry		 vs
history
Operating margin (%) -8.80
CUTR's Operating margin (%) is ranked lower than
671140% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 10.20 vs. CUTR: -8.80 )
CUTR' s 10-Year Operating margin (%) Range
Min: -20.8   Max: 22
Current: -8.8
-20.8
22
Net-margin (%) -8.5
CUTR's Net-margin (%) is ranked lower than
689654% of the 145 Companies
in the Global Medical Devices industry.

( Industry Median: 7.90 vs. CUTR: -8.5 )
CUTR' s 10-Year Net-margin (%) Range
Min: -32.9   Max: 18.3
Current: -8.5
-32.9
18.3
ROE (%) -7.2
CUTR's ROE (%) is ranked lower than
684931% of the 146 Companies
in the Global Medical Devices industry.

( Industry Median: 9.10 vs. CUTR: -7.2 )
CUTR' s 10-Year ROE (%) Range
Min: -17.5   Max: 190.8
Current: -7.2
-17.5
190.8
ROA (%) -5.8
CUTR's ROA (%) is ranked lower than
684931% of the 146 Companies
in the Global Medical Devices industry.

( Industry Median: 5.90 vs. CUTR: -5.8 )
CUTR' s 10-Year ROA (%) Range
Min: -14.6   Max: 18.7
Current: -5.8
-14.6
18.7
ROC (Joel Greenblatt) (%) -164.50
CUTR's ROC (Joel Greenblatt) (%) is ranked lower than
684931% of the 146 Companies
in the Global Medical Devices industry.

( Industry Median: 23.90 vs. CUTR: -164.50 )
CUTR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -1189.6   Max: 227.2
Current: -164.5
-1189.6
227.2
Revenue Growth (%) 7.9
CUTR's Revenue Growth (%) is ranked lower than
1052631% of the 95 Companies
in the Global Medical Devices industry.

( Industry Median: 7.50 vs. CUTR: 7.9 )
CUTR' s 10-Year Revenue Growth (%) Range
Min: -13.9   Max: 38.8
Current: 7.9
-13.9
38.8
EBITDA Growth (%) -15
CUTR's EBITDA Growth (%) is ranked lower than
1587300% of the 63 Companies
in the Global Medical Devices industry.

( Industry Median: 8.70 vs. CUTR: -15 )
CUTR' s 10-Year EBITDA Growth (%) Range
Min: -15   Max: 60.2
Current: -15
-15
60.2
EPS Growth (%) -23.3
CUTR's EPS Growth (%) is ranked lower than
1923075% of the 52 Companies
in the Global Medical Devices industry.

( Industry Median: 11.60 vs. CUTR: -23.3 )
CUTR' s 10-Year EPS Growth (%) Range
Min: -23.3   Max: 94.4
Current: -23.3
-23.3
94.4
» CUTR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades
Q2 2012

CUTR Guru Trades in Q2 2012

Charles Brandes 37,925 sh (+4.33%)
Mario Gabelli 560,885 sh (+0.54%)
Chuck Royce 10,700 sh (unchged)
Jim Simons 540,900 sh (-1.62%)
» More
Q3 2012

CUTR Guru Trades in Q3 2012

Jim Simons 555,100 sh (+2.63%)
Chuck Royce 10,700 sh (unchged)
Charles Brandes 37,920 sh (-0.01%)
Mario Gabelli 560,000 sh (-0.16%)
» More
Q4 2012

CUTR Guru Trades in Q4 2012

Jim Simons 578,600 sh (+4.23%)
Mario Gabelli 580,000 sh (+3.57%)
Chuck Royce 10,700 sh (unchged)
Charles Brandes 14,543 sh (-61.65%)
» More
Q1 2013

CUTR Guru Trades in Q1 2013

Steven Cohen 10,109 sh (New)
Jim Simons 670,100 sh (+15.81%)
Chuck Royce 10,700 sh (unchged)
Charles Brandes Sold Out
Mario Gabelli 575,000 sh (-0.86%)
» More
» Details

Insider Trades

Latest Guru Trades with CUTR

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Charles Brandes 2013-03-31 Sold Out $8.95 - $13.03 $ 9.48-17%0
Charles Brandes 2012-12-31 Reduce -61.65%$7.34 - $9.77 $ 9.4812%14543
Mario Gabelli 2011-03-31 Reduce -47.71%0.03%$8.08 - $9.94 $ 9.487%503085
Charles Brandes 2010-12-31 Add 102.41%$7.01 - $8.39 $ 9.4826%54255
Premium More recent guru trades are included for Premium Members only!!

Ratios

vs
industry		 vs
history
P/B 1.40
CUTR's P/B is ranked lower than
490196% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. CUTR: 1.40 )
CUTR' s 10-Year P/B Range
Min: 0.68   Max: 6.79
Current: 1.4
0.68
6.79
P/S 1.74
CUTR's P/S is ranked lower than
465116% of the 215 Companies
in the Global Medical Devices industry.

( Industry Median: 2.05 vs. CUTR: 1.74 )
CUTR' s 10-Year P/S Range
Min: 0.93   Max: 7.8
Current: 1.74
0.93
7.8
PFCF 94.80
CUTR's PFCF is ranked lower than
813007% of the 123 Companies
in the Global Medical Devices industry.

( Industry Median: 20.43 vs. CUTR: 94.80 )
CUTR' s 10-Year PFCF Range
Min: 9.76   Max: 1164
Current: 94.8
9.76
1164
EV-to-EBIT 333.3
CUTR's EV-to-EBIT is ranked lower than
558659% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 19.60 vs. CUTR: 333.3 )
CUTR' s 10-Year EV-to-EBIT Range
Min: 5.6   Max: 695.7
Current: 333.3
5.6
695.7
Shiller P/E 6258.3
CUTR's Shiller P/E is ranked lower than
100% of the Companies
in the Global Medical Devices industry.

( Industry Median: vs. CUTR: 6258.3 )
CUTR' s 10-Year Shiller P/E Range
Min: 23.19   Max: 6258.3
Current: 6258.3
23.19
6258.3

Valuation & Return

vs
industry		 vs
history
Price/Net Cash 2.2
CUTR's Price/Net Cash is ranked lower than
1449274% of the 69 Companies
in the Global Medical Devices industry.

( Industry Median: 10.90 vs. CUTR: 2.2 )
CUTR' s 10-Year Price/Net Cash Range
Min: 1.4   Max: 4.7
Current: 2.2
1.4
4.7
Price/Net Current Asset Value 8.2
CUTR's Price/Net Current Asset Value is ranked lower than
523560% of the 191 Companies
in the Global Medical Devices industry.

( Industry Median: 13.00 vs. CUTR: 8.2 )
CUTR' s 10-Year Price/Net Current Asset Value Range
Min: 7.2   Max: 28
Current: 8.2
7.2
28
Price/Tangible Book 1.6
CUTR's Price/Tangible Book is ranked lower than
520833% of the 192 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. CUTR: 1.6 )
CUTR' s 10-Year Price/Tangible Book Range
Min: 1   Max: 3.8
Current: 1.6
1
3.8
Price/DCF (Projected) 1.8
CUTR's Price/DCF (Projected) is ranked lower than
1369862% of the 73 Companies
in the Global Medical Devices industry.

( Industry Median: 1.50 vs. CUTR: 1.8 )
CUTR' s 10-Year Price/DCF (Projected) Range
Min: 0.7   Max: 1.7
Current: 1.8
0.7
1.7
Price/Median PS Value 0.8
CUTR's Price/Median PS Value is ranked lower than
510204% of the 196 Companies
in the Global Medical Devices industry.

( Industry Median: 1.00 vs. CUTR: 0.8 )
CUTR' s 10-Year Price/Median PS Value Range
Min: 0.6   Max: 2.2
Current: 0.8
0.6
2.2
Earnings Yield (Greenblatt) 0.30
CUTR's Earnings Yield (Greenblatt) is ranked lower than
591715% of the 169 Companies
in the Global Medical Devices industry.

( Industry Median: 4.90 vs. CUTR: 0.30 )
CUTR' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 17.8
Current: 0.3
0.1
17.8
Forward Rate of Return (Yacktman) -0.92
CUTR's Forward Rate of Return (Yacktman) is ranked lower than
1666665% of the 60 Companies
in the Global Medical Devices industry.

( Industry Median: 7.85 vs. CUTR: -0.92 )
CUTR' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 19.4   Max: 24.8
Current: -0.92
19.4
24.8

Business Description

Cutera, Inc. is a Delaware Corporation. It is a global medical device company headquartered in Brisbane, California specializing in the design, development, manufacture, marketing and servicing of laser and light-based aesthetics systems for practitioners worldwide. The Company offer easy-to-use products based on six platforms - CoolGlide, Xeo, Solera, GenesisPlusTM, Excel VTM, and myQTM - each of which enable physicians and other qualified practitioners to perform safe and effective aesthetic procedures for their customers. CoolGlide- In March 2003, its first product platform, CoolGlide, was launched. This platform offers laser applications for hair removal, treatment of a range of vascular lesions, including leg and facial veins, and Laser Genesis - a skin rejuvenation procedure that reduces fine lines, reduces pore size and improves skin texture. Xeo- In 2003, it introduced the Xeo platform, which can combine pulsed light and laser applications in a single system. The Xeo is a fully upgradeable platform on which a customer can use the following applications that it offers: remove unwanted hair, treat vascular lesions and rejuvenate the skin by treating discoloration, improving texture, reducing pore size and treating fine lines and laxity. Solera- In 2004, it introduced the Solera platform, a compact tabletop system designed to support a single technology platform. Solera systems use either infrared (Solera Titan) or pulsed light (Solera Opus) and can be used to remove unwanted hair, treat vascular lesions and rejuvenate the skin. The Solera Opus can support one or more pulsed light applications in a single system. GenesisPlus- In 2010, it introduced the GenesisPlus platform, which is a dedicated laser based system for performing skin rejuvenation procedures and for onychomycosis, or toenail fungus. This system has a hand piece that includes real time temperature monitoring of the treatment area, as well as a non-contact distance gauge using two aiming beams, for improving the clinical result of treatment. In addition, this system can be used to treat patients with skin concerns such as fine wrinkles, diffuse redness, rosacea, skin texture and pore size. Excel V- In February 2011, it introduced its Excel V platform, a high-performance, vascular platform designed specifically for the core-market of Dermatologists and Plastic Surgeons. This platform provides a combination of the 532 nm green laser with Cutera's award winning 1064 nm Nd:YAG technology, to provide a single, compact and efficient system that treats the entire range of cosmetic vascular conditions, without the need for costly consumables. myQ- In October 2011, it announced a distribution agreement with Quanta System SpA ─ an Italian Original Equipment Manufacturer (OEM) of laser technologies ─ to market and sell the myQ series of Q-switched lasers in Japan. The Company's products are medical devices subject to extensive and rigorous regulation by the U.S. Food a
Company Website
SEC Reports
Industry: Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ
» More Articles for CUTR

Headlines

Articles On GuruFocus.com
Weekly CFO Sells Highlight: MSCC, BMRN, VAL, CUTR, REX, CIEN Oct 02 2011 
Stocks Trading Below Net Cash: Adaptec Inc (ADPT), AuthenTec Inc (AUTH) and Cutera Inc (CUTR). Feb 16 2009 

Personalized Checklist





Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial